Resmed Inc. buy Needham & Company LLC
Start price
02.08.24
/
50%
€194.15
Target price
02.08.25
€216.62
Performance (%)
23.62%
End price
03.08.25
€240.00
Summary
This prediction ended on 03.08.25 with a price of €240.00. The prediction had a final performance of 23.62%. Dividends of €1.48 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -2.749% | -2.749% | -9.933% |
| iShares Core DAX® | 0.170% | 2.184% | 15.013% |
| iShares Nasdaq 100 | 0.515% | 0.370% | 6.226% |
| iShares Nikkei 225® | 1.614% | 6.357% | 21.242% |
| iShares S&P 500 | -0.719% | -0.275% | 1.451% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $236.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten